Bolivian hemorrhagic fever reappears
Loading...
Cite
Bolivian hemorrhagic fever reappears. (1995). [Journal articles]. https://iris.paho.org/handle/10665.2/26890
Date
1995
Document Number
ISBN
eISBN
ISSN
DOI
Authors
Other Language Versions
Description
Source: (1) CDC. Bolivian hemorrhagic fever- El Beni Department, Bolivia, 1994. Morb Mortal Wkly Rep 43(50):943-46, 1994. (2) Re-emergence of Bolivian hemorrhagic fever. Epidemiol Bull [PAHO] 15(4):4-5, 1994
Notes
Pages
Volume
Replaces
Table of contents
Link to WHO's original document
Link to WHO's original document
Category
Youtube URI
Citation
Status Mendates
Collections
License
Related items
Showing items related by metadata.
Item Epidemiological Alert, Outbreak of Bolivian Hemorrhagic Fever (BHF) Confirmed in the Department of Beni, Itenez Province, Bolivia (1 July 2004)(PAHO, 2004)The National Health Information System of the Ministry of Health and Sports of Bolivia reported the occurrence of two cases of Bolivian Hemorrhagic Fever (BHF) in the Department of Beni, Itenez Province, localities of Huacareje and Magdalena—an endemic area for BHF. Both patients, aged 30 and 16 respectively, died between 11 and 17 June 2004; to date, no more human cases have been reported in the above areas. On 23 June, the laboratory reported the serological confirmation for the Machupo Virus in one of the cases; the other is still pending.Item Epidemiological Bulletin, v. 15, n.4, Dic. 1994(PAHO, 1994)IN THIS ISSUE: The certification of wild poliovirus eradication from western hemisphere | Re-emergence of Bolivian Hemorrhagic Fever | Epidemiological surveillance in Haiti: experiences and outlook | Summer courses on epidemiology in 1995 | IV Cuban Congress of Hygiene and Epidemiology | Priorities of the Research Grants Program of the Pan American Health Organization, 1995-1998 | First Inter-American Conference on Society, Violence and Health.Item Epidemiological Alert: Hemorrhagic fever due to Arenavirus in Bolivia (18 July 2019)(PAHO, 2019)On 28 June 2019, the Ministry of Health of the Plurinational State of Bolivia received a report of 3 cases of hemorrhagic febrile syndrome of unknown etiology with suspected human-to-human transmission. As of 17 July 2019, there are a total of 5 cases, including 3 deaths. Of the total cases, 3 have been laboratory-confirmed (one fatal) and 2 have been classified as probable cases (both fatal). The cases had symptom onset between 29 April and 29 May 2019. Four of the 5 cases are male, with ages ranging between 21 to 65 years (median 42 years). Three of the cases are healthcare workers and the other 2 cases are agricultural workers.Item Toward a vaccine against Argentine hemorrhagic fever(1991)A vaccine against Argentine hemorrhagic fever, the "mal de los rastrojos" of the pampas, has been a dream of physicians and scientists involved with the disease since its regognition in the 1950s. Several killed and live immunogens have been produced and tested in pursuit of this goal, none of which has proved suitable for widespread human use. Recently, a new live-attenuated Junin virus vaccine. Candid #1, was developed through a cooperative international effort. Testing conducted to date indicates that this vaccine holds considerable promiseItem Clinical Management of Yellow Fever in the Region of the Americas. Experiences and Recommendations for Health Services(PAHO, 2023)The waves of yellow fever transmission in the Region of the Americas in 2016–2018 involved the largest number of human and epizootic cases to be reported in several decades. Yellow fever is a serious viral hemorrhagic disease that poses a challenge for health professionals. It requires early recognition of signs and symptoms, which are often nonspecific, and it can mimic other acute febrile syndromes. Early detection of suspected or confirmed cases, monitoring of vital signs, life support measures, and treatment of acute kidney failure continue to be the recommended strategies for case management. This report is the result of discussions among experienced specialists in the Americas on the clinical management of yellow fever patients, especially during outbreaks and epidemics, in the context of current medical and scientific evidence and taking into account the technical guidelines already available in the countries of the Region. It includes flowcharts for initially addressing patients with clinical suspicion of yellow fever and proposes a minimum package of laboratory tests that may be useful in contexts where resources are limited. In addition, it considers aspects of health system organization for dealing with yellow fever outbreaks and epidemics.